Geron (GERN) News
NASDAQ: GERNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.23+0.005 (+0.41%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GERN news summary
We found 1 recent headline mentioning Geron (GERN): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, GERN is up 0.41% at $1.23. The most recent story, "Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward?", was published by Nasdaq on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology